Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Avanos Medical (AVNS) Consolidated Net Income (2016 - 2024)

Avanos Medical (AVNS) has disclosed Consolidated Net Income for 11 consecutive years, with -$300000.0 as the latest value for Q4 2024.

  • Quarterly Consolidated Net Income rose 40.0% to -$300000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$300000.0 through Sep 2025, up 95.0% year-over-year, with the annual reading at -$5.8 million for FY2024, 88.82% up from the prior year.
  • Consolidated Net Income hit -$300000.0 in Q4 2024 for Avanos Medical, up from -$1.6 million in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of $38.5 million in Q2 2021 to a low of -$63.8 million in Q2 2023.
  • Historically, Consolidated Net Income has averaged -$4.6 million across 5 years, with a median of -$400000.0 in 2023.
  • Biggest five-year swings in Consolidated Net Income: skyrocketed 1383.33% in 2021 and later tumbled 928.57% in 2023.
  • Year by year, Consolidated Net Income stood at -$49.0 million in 2020, then soared by 47.55% to -$25.7 million in 2021, then skyrocketed by 128.02% to $7.2 million in 2022, then crashed by 106.94% to -$500000.0 in 2023, then skyrocketed by 40.0% to -$300000.0 in 2024.
  • Business Quant data shows Consolidated Net Income for AVNS at -$300000.0 in Q4 2024, -$1.6 million in Q3 2024, and -$2.5 million in Q2 2024.